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 In 2014, 1821 patients died awaiting a liver transplant in the United States while nearly 10% of 
livers recovered from deceased donors were not transplanted, usually because of concern that 
the donor liver would function poorly or not work at all (1). Ex vivo assessment of such donor 
livers by normothermic perfusion may mitigate such fears by demonstrating functional ability and 
thus permit transplantation. Here we describe the use of ex vivo normothermic perfusion to 
assess a liver deemed unfit for transplantation before it went on to be successfully transplanted 
after a 26 hour period of extracorporeal storage. 
The liver of a 39-year-old brain dead donor dying following hypoxic brain injury was offered for 
transplantation to all United Kingdom liver transplant units, but declined because of suboptimal 
in situ perfusion at the time of organ recovery. The liver was accepted for research at our centre 
and upon arrival, underwent normothermic perfusion with an erythrocyte-based perfusate using 
a Liver Assist machine (Organ Assist, Groningen, Netherlands), starting 618 minutes after cold in 
situ perfusion in the organ donor. At the end of the first hour the perfusate alanine transaminase 
(ALT) concentration was 284iu/L and the lactate concentration had fallen from 71mg/dL to 
4.5mg/dL (figure 1a). The liver maintained physiological pH without support and produced bile.  
Accordingly we therefore reversed our initial decision to decline the liver for transplantation and 
after 8.5 hours ex vivo normothermic perfusion the liver was flushed with cold Belzer UW 
solution (Bridge to Life, London, UK) and returned to cold storage pending implantation. The 
recipient was a 48-year-old man with primary sclerosing cholangitis and a Model for End-Stage 
Liver Disease score of 26 (2).  At operation a suspicious subcapsular liver nodule was found and 
subject to urgent histological characterisation by frozen section to rule out cholangiocarcinoma. 
This delayed implantation of the new liver contributed to 412 minutes of cold storage that 
followed normothermic perfusion before the liver was reperfused in the recipient. The total 
period of extracorporeal storage was 26 hours and one minute. Reperfusion was uneventful and 
 there was primary function with a peak ALT of 960iu/l on day 1, and normal liver chemistry by 
day 26 (figure 1b). 
Liver transplantation is limited by a shortage of suitable donor organs (3), yet potentially usable 
livers such as the one described here are being discarded, due to uncertainty regarding their 
ability to support life following transplantation. This situation has been heightened in recent 
years by the use of livers donated after circulatory death or with other factors associated with 
poor outcomes (4, 5).  The ability to assess dynamic liver function and hepatocellular injury 
following a period of warm and/or cold ischaemia enables an informed decision to be made 
regarding the suitability of an organ and may, as in this case, permit use of livers that would 
otherwise have been discarded.  The period of normothermic perfusion also allows reperfusion to 
occur in the absence of some of the mediators of reperfusion injury, such as leucocytes, platelets 
and complement, and provides an opportunity to pharmacologically manipulate the liver to 
further reduce reperfusion injury in the recipient.   
This is the longest reported successful period of storage of a human liver before transplantation, 
with normal cold storage times being less than half the 26 hour period herein reported. The 
extended preservation in this case, involving an intermediate period of normothermia 
sandwiched between two extended periods of cold ischaemia, suggests that ex situ evaluation 
and treatment of the liver may take place remote from the transplant centre, to where it may be 
transported by traditional simple cold storage for implantation. Such a hub and spoke model may 
be the future of organ assessment and resuscitation of marginal organs before transplantation.  
In an era when proposed changes in liver allocation in the US are causing concern regarding 
possible increased cold ischaemia times and the deleterious consequences, techniques such as 
normothermic perfusion hold much promise. 
 Figure 1.  Biochemistry (a) during perfusion and (b) following transplantation.  
Lactate concentration in the perfusate fell rapidly during the first hour of normothermic 
perfusion (1a) with minimal transaminase release.  Post transplant liver function is shown in (1b). 
Figure 1a 
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